Predicting no-reflow phenomenon prior to primary percutaneous coronary intervention using a novel probability risk score derived from clinical and angiographic parameters.

MLA

Stajic, Z., et al. “Predicting No-Reflow Phenomenon Prior to Primary Percutaneous Coronary Intervention Using a Novel Probability Risk Score Derived from Clinical and Angiographic Parameters.” European Review for Medical and Pharmacological Sciences, vol. 26, no. 3, Feb. 2022, pp. 759–70. EBSCOhost, https://doi.org/10.26355/eurrev_202202_27984.

APA

Stajic, Z., Milicevic, D., Kafedzic, S., Aleksic, A., Cerovic, M., Tasic, M., Andjelkovic Apostolovic, M., Ignjatovic, A., Zornic, N., Obradovic, G., Jovanovic, V., Jagic, N., Neskovic, A. N., & Davidovic, G. (2022). Predicting no-reflow phenomenon prior to primary percutaneous coronary intervention using a novel probability risk score derived from clinical and angiographic parameters. European Review for Medical and Pharmacological Sciences, 26(3), 759–770. https://doi.org/10.26355/eurrev_202202_27984

Chicago

Stajic, Z, D Milicevic, S Kafedzic, A Aleksic, M Cerovic, M Tasic, M Andjelkovic Apostolovic, et al. 2022. “Predicting No-Reflow Phenomenon Prior to Primary Percutaneous Coronary Intervention Using a Novel Probability Risk Score Derived from Clinical and Angiographic Parameters.” European Review for Medical and Pharmacological Sciences 26 (3): 759–70. doi:10.26355/eurrev_202202_27984.